Exploring 3-Fluoroamphetamine. To explore a different substance…

Names:
3-FA · 3-F-AMP · 3-Fluoroamphetamine
IUPAC name:
1-(3-Fluorophenyl)propan-2-amine
ID: 2130 · Formula: C9H12FN · Molecular weight: 153.197
InChI: InChI=1S/C9H12FN/c1-7(11)5-8-3-2-4-9(10)6-8/h2-4,6-7H,5,11H2,1H3

Segawa, H; Iwata, YT; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Kanamori, T; Inoue, H. Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography: Differentiation of ring-substituted regioisomers by supercritical fluid chromatography. Drug Test. Analysis, 1 Jan 2016, 9 (3), 389-398. 1.3 MB. http://dx.doi.org/10.1002/dta.2040

Rothman, RB; Blough, BE; Baumann, MH. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J., 2007, 9 (1), E1–E10. 999 kB. http://dx.doi.org/10.1208/aapsj0901001

Baumann, MH; Clark, RD; Woolverton, WL; Wee, S; Blough, BE; Rothman, RB. In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J. Pharmacol. Exp. Ther., 1 Apr 2011, 337 (1), 218–225. 380 kB. http://dx.doi.org/10.1124/jpet.110.176271

Rothman, RB; Blough, BE; Baumann, MH. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. Trends Pharmacol. Sci., 1 Dec 2006, 27 (12), 612–618. 519 kB. http://dx.doi.org/10.1016/j.tips.2006.10.006

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. http://dx.doi.org/10.1016/j.forsciint.2011.11.003

Westphal, F; Rõsner, P; Junge, T. Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci. Int., 30 Jan 2010, 194 (1–3), 53–59. 521 kB. http://dx.doi.org/10.1016/j.forsciint.2009.10.007

Rõsner, P; Quednow, B; Girreser, U; Junge, T. Isomeric fluoro-methoxy-phenylalkylamines: A new series of controlled-substance analogues (designer drugs). Forensic Sci. Int., 1 Jan 2004, 148 (2–3), 143–156. 282 kB. http://dx.doi.org/10.1016/j.forsciint.2004.05.003

3-FMA · 3-Fluoromethamphetamine
N-Et-3-FA · 3-Fluoroethamphetamine
2506
2507
2508
2509
2510
3-F-PEA
PAL-314 · 3-Methylamphetamine
3-MA · 3-Methoxyamphetamine
A · Amphetamine
3-TFMA · Norfenfluramine
3-HA · Gepefrine
3-CA · 3-Chloroamphetamine
3-EA
3-MTA
3-Br-AMP · 3-Bromoamphetamine
3-IA
2135
DFA · 3,4-Difluoroamphetamine
2720
4-FA · 4-Fluoroamphetamine
2-F-AMP · 2-Fluoroamphetamine
β-FA
α-FA
N-Me-2-F-PEA
N-Me-3-F-PEA
N-Me-4-F-PEA
3-FMA · 3-Fluoromethamphetamine
N-Et-3-FA · 3-Fluoroethamphetamine
2506
2507
2508
2509
2510
3-F-PEA
PAL-314 · 3-Methylamphetamine
3-MA · 3-Methoxyamphetamine
A · Amphetamine
3-TFMA · Norfenfluramine
3-HA · Gepefrine
3-CA · 3-Chloroamphetamine
3-EA
3-MTA
3-Br-AMP · 3-Bromoamphetamine
3-IA
2135
DFA · 3,4-Difluoroamphetamine
2720
4-FA · 4-Fluoroamphetamine
2-F-AMP · 2-Fluoroamphetamine
β-FA
α-FA
N-Me-2-F-PEA
N-Me-3-F-PEA
N-Me-4-F-PEA
13 December 2017 · Creative Commons BY-NC-SA ·